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Background: Production of chimeric mice is a useful tool for the elucidation of gene function. After successful
isolation of embryonic stem (ES) cell lines, there are many methods for producing chimeras, including co-culture
with the embryos, microinjection of the ES cells into pre-implantation embryos, and use of tetraploid embryos to
generate the full ES-derived transgenic mice. Here, we aimed to generate the transgenic ES cell line, compare the
production efficiency of chimeric mice and its proportion to yield the male chimeric mice by microinjected ES cells
into 4- to 8-cell and blastocysts embryos with the application of Piezo-Micromanipulator (PMM), and trace the fate
of the injected ES cells.
Results: We successfully generated a transgenic ES cell line and proved that this cell line still maintained
pluripotency. Although we achieved a satisfactory chimeric mice rate, there was no significant difference in the
production of chimeric mice using the two different methods, but the proportion of the male chimeric mice in the
4- to 8-cell group was higher than in the blastocyst group. We also found that there was no tendency for ES cells
to aggregate into the inner cell mass using in vitro culture of the chimeric embryos, indicating that they
aggregated randomly.
Conclusions: These results showed that the PMM method is a convenient way to generate chimeric mice and
microinjection of ES cells into 4- to 8-cell embryos can increase the chance of yielding male chimeras compared to
the blastocyst injection. These results provide useful data in transgenic research mediated by ES cells.
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Embryonic stem (ES) cells derived from the inner cell
mass (ICM) of blastocysts can maintain their self-
renewal during in vitro culture and have the amazing
ability of developing into all three germ layers, including
germ cells [1]. The ES cells can be genetically manipu-
lated in vitro by introducing targeted mutations and
other genetic alterations into the mice genome, provid-
ing a powerful tool for understanding gene function
in vivo [1-7] and contributing significantly to biomedical
research [8,9]. Due to the powerful function of ES cells,
chimeras have become important tools for the study of
cell lineage differentiation and embryogenesis. In 1961,* Correspondence: sqzhang@scau.edu.cn
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reproduction in any medium, provided the orthe first chimeric mice were generated by aggregation of
two 8-cell stage embryos [10]. Since then, different
methods of producing chimeric mice and more efficient
equipment have been created. Until now, the production
of chimeras by microinjected genetically modified ES
cells into blastocysts or zygotes [11,12] or 8-cell stage
embryos [13] was successful. In addition, chimeric mice
can also be produced by aggregation of ES cells with
cleavage embryos [14-16]. The Piezo-Micromanipulator
(PMM) method, which originally was successfully used
for intracytoplasmic sperm injection (ICSI) and somatic
cell cloning [17,18], was also used in chimeric mice pro-
duction [19]. Laser-assistance of injecting ES cells into
8-cell stage embryos could more efficiently produce F0
ES mice with full germ-line transmission compared to
the tetraploid complementation method [20]. Recently,
Huang report that injection of ES cells into 4- or 8-cellThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Primers used for detection of pluripotency
marker genes
Gene Sequences Length, bp
Oct4 CTG AGG GCC AGG CAG GAG CAC GAG 485
CTG TAG GGA GGG CTT CGG GCA CTT
Nanog AGG GTC TGC TAC TGA GAT GCT 363
CAA CAC CTG GTT TTT CTG CCA CCG
Sox-2 GGT TAC CTC TTC CTC CCA CTC CAG 193
TCA CAT GTG CGA CAG GGG CAG
Rex-1 ACG AGT GGC AGT TTC TTC TTG GGA 287
TAT GAC TCA CTT CCA GGG GGC ACT
β-actin CCG CCA CCA GTT CGC CAT G 778
CCG CTC GTT GCC AAT AGT GAT GAC
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produce the F0 ES cell offspring [21].
In the present study, we generated an EGFP-ES cell
line and tested the efficiency of producing chimeric mice
by injecting the ES cells into 4- to 8-cell and blastocyst
embryos with the application of PMM. The proportion
of male chimeric mice and in vitro development of the
chimeric embryos was also analyzed.
Methods
Embryos and recipient mice
All animal procedures were performed according to
guidelines developed by the China Council on Animal
Care and protocols were approved by the Animal Care
and Use Committee of Guangdong Province, China. The
approval ID or permit numbers are SCXK (Guangdong)
2004–0011 and SYXK (Guangdong) 2007–0081.
CD-1 females were superovulated by intraperitoneal
injection of 5 IU pregnant mare serum gonadotro-
phin followed by 5 IU human chorionic gonadotrophin
(HCG) 46 to 48 h later. After the HCG injection, these
female mice were mated with male mice of the same
strain. Females were screened for vaginal plugs the fol-
lowing morning (0.5 d post coitum, [dpc]), and fertilized
embryos were collected and cultured in potassium sim-
plex optimization medium (KSOM), overlaid with
embryo-tested mineral oil in humidified atmospheres of
5% CO2 at 37°C. CD-1 females were mated with vasecto-
mized CD-1 males and used as recipients for embryo
transfer at 0.5 or 2.5 dpc. Unless otherwise specified, all
reagents were obtained from Sigma-Aldrich.
Transgenic ES cell line and culture
We used the R1 ES cell line, routinely cultured on
inactivated cellular feeder layers in ES cell medium, com-
posed of Dulbecco’s modified Eagle’s medium (Gibco),
supplemented with 20% fetal bovine serum (Gibco),
1% nonessential amino acid (Gibco), 0.1 mmol/L β-
mercaptoethanol (Gibco), 1 mmol/L glutamine (Gibco), 1%
nucleosides (Gibco), 50 units/mL penicillin, 50 μg/mL
streptomycin (Gibco) and 1,000 units/mL recombinant
mice leukemia inhibitory factor (Millipore). ES cells were
electroporated with the linearized pEGFP-N1 (Clontech)
by using a BTX Electroporation Generator (BTX, Inc.,
San Diego, CA) at 250 V and 90 μs. Neomycin (Gibco) se-
lection was performed 2 d after transfection to obtain stable
transgenic ES cell lines.
Characterization of transgenic ES cell line
Immunohistochemistry and AP staining
ES cells grown on feeder cells were fixed in 4% parafor-
maldehyde for 20 min, permeabilized with 0.2% Triton
X-100 for 30 min, and blocked in 3% bovine serum albu-
min in phosphate-buffered saline (PBS) for 2 h. Cellswere incubated with primary antibody overnight at 4°C,
washed, and incubated with Alexa Fluor (Invitrogen) sec-
ondary antibody for 3 h. Oct4 and Sox-2 antibodies were
obtained from Millipore. Alkaline phosphatase staining
was done according to the manufacturer’s recommenda-
tions (Millipore).
Teratoma formation
ES cells were washed with PBS, trypsinized to obtain a
single-cell suspension, and collected by centrifugation.
2×106 cells were subcutaneously injected into immune-
deficient BALB/cA-nu mice. 4 wk after injection, teratomas
were dissected, rinsed once with PBS, and fixed in 10% for-
malin. Teratomas were embedded in paraffin, sectioned,
stained with hematoxylin/eosin, and then visualized with a
Olympus(IX71) microscope and photographed.
Expression analysis of pluripotency marker genes by RT-PCR
Reverse-transcription polymerase chain reaction (RT-PCR)
was performed to evaluate the pluripotency of ES cells.
Total RNA was isolated from ES cells using an RNAprep
Cell/Bacteria Kit (TIANGEN) according to the manufac-
turer’s protocol. We subjected 0.5 μg of RNA to the RT re-
action using Superscript (TaKaRa). PrimeSTARW HS DNA
Polymerase (TaKaRa) was used for the PCR reaction.
Primers used are listed in Table 1 [22].
In vitro formation of embryoid body
ES cells were washed with PBS, trypsinized, resuspended
with embryoid body (EB) medium (without LIF), and
20- to 30-μL drops containing 400 to 1,000 ES cells were
plated on the lid of petri dishes in regular arrays. A 100-
mm dish can accommodate approximately 30 to 40
drops. The lid was inverted and placed over the bottom
of a petri dish filled with PBS to prevent the drops from
drying out. The petri dishes with hanging drops were
incubated for 2 d. Embryoid body-like aggregates were
harvested and subsequently transferred into bacterial-
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ferentiation, 5 to 7-d-old EBs were plated on gelatin-
coated tissue culture plates.
Chimera production
Microinjection
The ES cells were injected into the mice embryos by
PMM as described [17-19]. Fertilized embryos were cul-
tured in KSOM in vitro until 2.0 dpc, 2.5 dpc, and 3.5
dpc for the production of 4- to 8-cell and blastocyst em-
bryos. ES cells were trypsinized to obtain a single-cell
suspension, and the cell suspension was kept on ice in 1
mL ES cell medium with HEPES in a 15-mL tube until
use. Ten to fifteen ES cells were injected into the 4- and
8-cell and blastocyst embryos, injected blastocysts were
cultured in KSOM at 37°C in an atmosphere of 5% CO2
for 1 to 2 h until the blastocyst cavity was recovered.
Embryo transfer
Healthy microinjected 4- to 8-cell embryos were surgi-
cally transferred to the oviduct of 0.5 dpc pseudopreg-
nant female recipients. The microinjected blastocysts
were transferred to the uterine horns of 2.5 dpc pseudo-
pregnant females using the standard procedure.
Fluorescence microscope
In vitro development of 4-cell stage embryos injected
with ES cells were observed with an Olympus inverted
fluorescence microscope until the blastocysts hatched.
Statistical analysis
In the efficiency of chimera production experiment, the
data was processed with SPSS 17.0 (SPSS Inc., Chicago, IL)
statistical software. Significance was declared at P≤0.05.Figure 1 Transgenic ES cell clones and expansion culture. Two wk afte
picked under the fluorescence microscope (A). These cells were expandedResults
Production of transgenic ES cell line
To investigate and easily observe the in vitro develop-
ment of chimeric embryos, we first generated the trans-
genic ES cell line. Linearized pEGFP-1 was introduced
into the R1 ES cell line by electroporation using the BTX
(T820) electroporator. The G418 selection was performed
24 h later, and after 2 wk, selection of the positive clones
was observed using the fluorescent microscope (Figure 1A).
Next, the positive ES clones, which had normal morph-
ology, were picked and expanded in culture, and success-
fully generated the transgenic ES cell line that expressed
EGFP (Figure 1B).
Characterization of transgenic ES cell line
To confirm that the transgenic ES cell line retained its
stem cell properties, we examined them for expression
of pluripotency markers. As shown in Figure 2, the ES
cell clones still have normal morphology (Figure 2A, left):
apparent clone boundaries, high refractivity, tight, round
colonies of cells with a high nucleus to cytoplasm ratio,
and stained for AP (Figure 2A, right). When the ES cells
were allowed to form EBs by suspension culture, embryoid
body-like aggregates were formed after five days in culture
(Figure 2B, left), and we observed outgrowths after plating
them onto tissue culture plates (Figure 2B, right). Next,
we injected ES cells subcutaneously into immunodeficient
mice. 4 wk later, upon histological examination, the ES cell
line gave rise to teratomas (Figure 2C) that contained
derivatives of all three germ layers, including gut-like
epithelium (endoderm), cartilage (mesoderm), and epider-
mal tissues (exoderm). Immunocytochemistry revealed
that the ES cells expressed Oct4 and Sox-2 (Figure 2D).
RT-PCR analysis revealed that the ES cells expressed
marker transcripts for Oct4, Nanog, Sox-2 and Rex-1r selection, the positive and normal ES morphologic clones were
and all expressed the exogenous EGFP protein (B).
Figure 2 Characterization of transgenic ES cell line. Normal morphologic ES clones were visible under the phase-contrast microscope and
stained positive for AP (A). Using the handing drop method, the ES cells formed the embryo-like aggregates and outgrowths after plating them
onto tissue culture plates (B). Teratoma formation in immunodeficiency mice from injected ES cells. Hematoxylin and eosin staining was
performed on the teratomas. The resulted teratomas contained tissues representing all three germ layers: endoderm, gut-like epithelium;
mesoderm, cartilage; exoderm, epidermal tissues (C). Immunofluorescence analysis of ES cells for pluripotency markers. The clones express the
embryonic markers Oct4 and Sox-2. Nuclei were stained with hoechst 33342. Underlying fibroblasts provide a negative control (D). RT-PCR analysis
of ES cell marker genes Oct4, Nanog, Sox-2, and Rex-1; β-actin was used as the loading control. M: DL 2000 DNA Marker (E).
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their pluripotency.
Generation of chimeric embryos and mice
To compare the production rate of chimeric mice, we
injected the ES cells into the 4- to 8-cell and blastocyst
stage embryos with the application of PMM (Figure 3A).
The injected blastocysts were cultured in KSOM me-
dium until the blastocele was retrieved. As shown in
Table 2, the blastocyst group was higher but no signifi-
cant difference was observed between it and the 4- to 8-cellgroup on the percentage of total born and chimeric mice.
In addition, the production of male chimeric mice was
higher in the latter group but no significant difference oc-
curred. We could not yield the F0 ES cell mice based on
100% coat color. To investigate the fate of ES cells and
chimeric embryo development in vitro, we used a fluores-
cent microscope to observe the injected 4- to 8-cell em-
bryos until they hatched. We observed EGFP expression in
the hatched blastocysts (Figure 3B), but most of the ES
cells allocated to the trophectoderm layers, and had no ap-
parent tendency to integrate into the ICM. They appeared
Figure 3 Generation of chimeric embryos and mice using the PMM method. Four- to eight-cell and blastocyst stage embryos were injected
with 10–15 ES cells with the application of Piezo (A). The in vivo development of transgenic 4- to 8-cell stage embryos injected with ES cells was observed
under the fluorescence microscope (B, black arrow: ICM). Chimeras were obtained from injecting the ES cells into the embryos (C). Scale bar = 20 μm.
Hu et al. Journal of Animal Science and Biotechnology 2013, 4:12 Page 5 of 7
http://www.jasbsci.com/content/4/1/12to integrate randomly. This result was consistent with the
production rate of chimeric mice.
Discussion
Studies on the control of gene expression in eukaryotes
based on the ability to induce the transient and stableexpression in mammalian cells have contributed greatly
to our current knowledge of the molecular mechanisms
governing regulation of gene expression. An individual
gene proved to be repaired using homologous recombin-
ation in ES cells [23] and the first genetically engineered
mutant mouse was generated in 1990 [3,24] after the
Table 2 Efficiency in the production of chimeras from ES cells injected into 4- to 8-cell and blastocyst stage embryos
Host embryo No. injected embryos transferred No. recipient mice No. total born (%) No. total chimeras (%) No. total male (%)
4- to 8- cell 248 6 27 (10.89) 12 (44.4) 9 (75)
blastocyst 618 20 80 (12.9) 42 (52.5) 28 (66.7)
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transfection methods have been developed to transfer
particles into cells including calcium phosphate DNA
precipitates [25], viral vectors [26], liposomes [27] and
direct injection of genes into the nucleus. However, use
of these methods is limited because: (1) they work effi-
ciently in only limited cell types and most are adherent
cells; and (2) cells transfected with these methods are
subject to a high frequency of damage. Subsequently, a
physical method that induces an enormous enhance-
ment of DNA transport across cellular membranes was
reported [28,29]. Briefly, using the short electric im-
pulses above a certain field, the membrane structure was
permeable and it was convenient for the material to
cross without damaging it. In addition, these methods
were also used in embryo fusion. We also compared
electroporation and liposome-mediated transfection, and
found that not only the transfection efficiency but also
the quality of the positive clones was superior after elec-
troporation versus liposomes.
Various techniques have been developed to maintain
the developmental potential of ES cells in vitro [30] and
restrict the developmental potential of host embryos to
increase the efficiency of germline chimeric mice pro-
duction [31,32]. Tetraploid complement was the most effi-
cient method to generate viable and fertile ES mice
completely from ES cells [33] and it's the “gold standard”
to test pluripotency of the cell lines. Unfortunately, tetra-
ploid embryos are less viable than normal embryos; mice
produced by this method have nonspecific lethality and
congenital abnormalities and complications in phenotypic
analysis [20]. Previous observations showed that injection
of ES cells at an earlier stage might increase degrees of ES
cell contribution [20], and high viable germline chimeras
were obtained by 8-cell embryo injection [13]. With the
application of laser and PMM, F0 ES mice with full
germline transmission were generated successfully [21].
In the present study, we aimed to compare the effi-
ciency of chimeric mice production with the PMM
method by injecting high passage (over 35) ES cells into
the 4- to 8-cell and blastocysts embryos. Our results
showed that the efficiency of chimeras did not differ be-
tween the two types of embryo injection, but all were
higher than previously reported [19]. In 8-cell injection,
the efficiency of chimera production and the proportion
of male mice was much lower than previously reported
[13]. We were unable to yield the F0 mice based on
100% coat color, which was not consistent with previousreports [13,20,21]. We traced the fate of ES cells in
chimeric embryos and found that ES cells did not prefer-
entially allocate to the ICM. This was in accordance with
the data on chimera production. Reports showed that
the combination of the genotypes of ES cells and host
blastocysts is important for production of germline
transmission chimeras, and the C57BL/6 are the suitable
host for 129-derived ES cells [3,34]. In this study, ES
cells were derived from 129 mice and had been cultured
in vitro for a long time (over 35 passages). Although they
retained their pluripotency, they might not be suitable
for generating chimeras. Wang report that R1 cells lost
their totipotency in producing viable ES mice after pas-
sage 14 and the CD-1 host embryos may have been un-
satisfactory with the combination of ES cells [35].
Conclusions
In the present study, we successfully generated a transgenic
ES cell line and we gained satisfactory efficiency of chimera
production by injecting into 4- to 8-cell and blastocyst em-
bryos with the PMM method, but we found no significant
difference between the two types of injection. The injected
ES cells had no tendency to integrate into the ICM of the
embryos based on tracing the ES cell fate. Interestingly, we
yielded a higher proportion of male chimeras by injecting
ES cells into 4- to 8-cell stage embryos than blastocyst in-
jection. In addition, the PMM method is an efficient way
to generate chimeric mice. These results show that these
methods provide another approach to developing trans-
genic mice derived from ES cells.
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